Toolkit/constrained peptides

constrained peptides

Construct Pattern·Research·Since 2021

Taxonomy: Mechanism Branch / Architecture. Workflows sit above the mechanism and technique branches rather than replacing them.

Summary

The development of constrained peptides represents an emerging strategy to generate peptide-based PPI inhibitors, typically mediated by α-helices.

Usefulness & Problems

Why this is useful

Constrained peptides are peptide constructs engineered with a conformational constraint to act as protein-protein interaction inhibitors, often in α-helical formats. The review frames them as a strategy for modulating difficult intracellular interaction surfaces.; generating peptide-based inhibitors of protein-protein interactions; stabilizing α-helix-mediated binding motifs; improving peptide affinity, stability, and cellular penetration

Source:

Constrained peptides are peptide constructs engineered with a conformational constraint to act as protein-protein interaction inhibitors, often in α-helical formats. The review frames them as a strategy for modulating difficult intracellular interaction surfaces.

Source:

generating peptide-based inhibitors of protein-protein interactions

Source:

stabilizing α-helix-mediated binding motifs

Source:

improving peptide affinity, stability, and cellular penetration

Problem solved

They are intended to improve the tractability of peptide-based PPI inhibition by increasing affinity, stability, and cellular penetration. The design logic also aims to reduce entropic penalties and protease-sensitive conformations.; addresses the difficulty of therapeutically targeting protein-protein interactions with peptides; reduces conformational and proteolytic liabilities of unconstrained peptides

Source:

They are intended to improve the tractability of peptide-based PPI inhibition by increasing affinity, stability, and cellular penetration. The design logic also aims to reduce entropic penalties and protease-sensitive conformations.

Source:

addresses the difficulty of therapeutically targeting protein-protein interactions with peptides

Source:

reduces conformational and proteolytic liabilities of unconstrained peptides

Problem links

addresses the difficulty of therapeutically targeting protein-protein interactions with peptides

Literature

They are intended to improve the tractability of peptide-based PPI inhibition by increasing affinity, stability, and cellular penetration. The design logic also aims to reduce entropic penalties and protease-sensitive conformations.

Source:

They are intended to improve the tractability of peptide-based PPI inhibition by increasing affinity, stability, and cellular penetration. The design logic also aims to reduce entropic penalties and protease-sensitive conformations.

reduces conformational and proteolytic liabilities of unconstrained peptides

Literature

They are intended to improve the tractability of peptide-based PPI inhibition by increasing affinity, stability, and cellular penetration. The design logic also aims to reduce entropic penalties and protease-sensitive conformations.

Source:

They are intended to improve the tractability of peptide-based PPI inhibition by increasing affinity, stability, and cellular penetration. The design logic also aims to reduce entropic penalties and protease-sensitive conformations.

Taxonomy & Function

Primary hierarchy

Mechanism Branch

Architecture: A reusable architecture pattern for arranging parts into an engineered system.

Target processes

No target processes tagged yet.

Implementation Constraints

cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationoperating role: actuatorswitch architecture: uncaging

Implementation requires a peptide sequence and a constraining chemistry that enforces a preferred conformation. The abstract supports use across multiple constraining chemistries and targets but does not specify a single required platform.; requires introduction of a conformational constraint; is typically applied to α-helix-mediated PPI inhibitor designs

The review notes that adding a constraint does not guarantee a simple benefit, because it can also alter binding dynamics, recognition mode, and other molecular properties. Thus constraint insertion alone does not fully predict successful function.; introducing a constraint can also change binding dynamics; introducing a constraint can alter the mode of recognition; molecular-property consequences are more subtle than simple preorganization

Validation

Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication

Supporting Sources

Ranked Claims

Claim 1design caveatsupports2021Source 1needs review

Constraint insertion can also produce subtler effects, including changes in binding dynamics, mode of recognition, and molecular properties.

Claim 2mechanistic rationalesupports2021Source 1needs review

The design rationale for constrained peptides is that pre-organization can pay the entropic cost of binding, reduce adoption of protease-compliant β-strand conformations, and shield hydrophilic amides from the hydrophobic membrane.

Claim 3property effectsupports2021Source 1needs review

Introducing a conformational constraint into peptide PPI inhibitors can enhance affinity, stability, and cellular penetration.

Claim 4review summarysupports2021Source 1needs review

Constrained peptides are an emerging strategy for generating peptide-based inhibitors of protein-protein interactions, typically through α-helix-mediated designs.

Approval Evidence

1 source4 linked approval claimsfirst-pass slug constrained-peptides
The development of constrained peptides represents an emerging strategy to generate peptide-based PPI inhibitors, typically mediated by α-helices.

Source:

design caveatsupports

Constraint insertion can also produce subtler effects, including changes in binding dynamics, mode of recognition, and molecular properties.

Source:

mechanistic rationalesupports

The design rationale for constrained peptides is that pre-organization can pay the entropic cost of binding, reduce adoption of protease-compliant β-strand conformations, and shield hydrophilic amides from the hydrophobic membrane.

Source:

property effectsupports

Introducing a conformational constraint into peptide PPI inhibitors can enhance affinity, stability, and cellular penetration.

Source:

review summarysupports

Constrained peptides are an emerging strategy for generating peptide-based inhibitors of protein-protein interactions, typically through α-helix-mediated designs.

Source:

Comparisons

Source-stated alternatives

The abstract contrasts constrained peptides implicitly with unconstrained peptide inhibitors. It also notes that multiple constraining chemistries exist rather than a single universal solution.

Source:

The abstract contrasts constrained peptides implicitly with unconstrained peptide inhibitors. It also notes that multiple constraining chemistries exist rather than a single universal solution.

Source-backed strengths

can enhance affinity; can enhance stability; can enhance cellular penetration; can pre-organize peptides for binding

Source:

can enhance affinity

Source:

can enhance stability

Source:

can enhance cellular penetration

Source:

can pre-organize peptides for binding

constrained peptides and alpha-helical domain linker address a similar problem space.

Shared frame: same top-level item type; shared mechanisms: conformational_uncaging

Compared with KnChR

constrained peptides and KnChR address a similar problem space.

Shared frame: same top-level item type; shared mechanisms: conformational_uncaging

Strengths here: looks easier to implement in practice; may avoid an exogenous cofactor requirement.

Compared with SPACECAT

constrained peptides and SPACECAT address a similar problem space.

Shared frame: same top-level item type; shared mechanisms: conformational_uncaging

Strengths here: looks easier to implement in practice.

Ranked Citations

  1. 1.
    StructuralSource 1Chemical Science2021Claim 1Claim 2Claim 3

    Seeded from load plan for claim cl1. Extracted from this source document.